XML 16 R4.htm IDEA: XBRL DOCUMENT v3.23.1
CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Operating Expenses:    
Research and development $ 5,430 $ 6,518
General and administrative 3,543 2,895
Total operating expenses 8,973 9,413
Loss from operations (8,973) (9,413)
Other income (expense):    
Grant income 3,426 5,904
Other expense, net (615) (195)
Interest expense (10) (9)
Total other income, net 2,801 5,700
Loss before income tax (6,172) (3,713)
Income tax expense   (125)
Net Loss (6,172) (3,838)
Net loss attributable to common stockholders (6,172) (3,838)
Unrealized gain on foreign currency translation 4 1
Total comprehensive loss $ (6,168) $ (3,837)
Net loss per share, basic (in dollars per share) $ (0.21) $ (0.17)
Net loss per share, diluted (in dollars per share) $ (0.21) $ (0.17)
Weighted-average common shares outstanding, basic (in shares) 29,094,592 22,426,982
Weighted-average common shares outstanding, diluted (in shares) 29,094,592 22,426,982